May 17, 2026 a 08:00 am
BSX: Fundamental Ratio Analysis - Boston Scientific Corporation
As a leader in the medical device field, Boston Scientific Corporation (BSX) shows promising growth potential driven by innovative technologies. With a solid presence in the MedSurg, Rhythm and Neuro, and Cardiovascular sectors, the company's strategic focus appears robust. Analysts predict steady performance, although regulatory changes and market competition pose challenges.
Fundamental Rating
BSX showcases a strong set of fundamentals, reflected in its overall score, displaying resilience and growth potential in the competitive healthcare landscape.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
Comparison of current and previous period scores gives insights into BSX's performance trajectory over time.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | 4 | 5 | 4 | 5 | 2 | 2 | 2 |
| Previous Date | 0 | 5 | 4 | 5 | 2 | 2 | 2 |
Analyst Price Targets
Analysts' price targets suggest potential for future growth, with a consensus around the median target.
| High | Low | Median | Consensus |
|---|---|---|---|
| $120 | $60 | $90 | $91.33 |
Analyst Sentiment
The overall sentiment from analysts indicates a favorable outlook for BSX.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 39 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Boston Scientific Corporation displays a strong fundamental foundation, bolstered by innovative products across key medical device sectors. While the company's stock is bolstered by a "Buy" consensus among analysts, investors should remain aware of the competitive and regulatory risks inherent in the healthcare industry. BSX is well-positioned for growth, but prudent observation of market conditions and company strategies remains essential to leverage investment opportunities effectively.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years